当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
ERVEBO, Ebola Zaire Vaccine, Live
申请企业
Merck Sharp & Dohme Corp.
药品名称
ERVEBO, Ebola Zaire Vaccine, Live
承诺描述
Deferred study V920-016 to evaluate the safety and immunogenicity of ERVEBO in children 12 months through 17 years of age.